Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Investors: Free Options Reports for Apple, Mattel Inc, Morgan Stanley, Pfizer Inc. and Reynolds American Incorporated

InvestorsObserver issues critical PriceWatch Alerts for AAPL, MAT, MS, PFE, and RAI.

What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?

Johnson & Johnson (JNJ), the bellwether of healthcare companies, is scheduled to report fourth-quarter 2016 and full-year results on Jan 24.

Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson

Today, Stock-Callers.com takes another look at the Drug Manufacturers space to see how current market conditions are influencing the performances of some major players in the industry. Under evaluation...

Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended

Eli Lilly and Company (LLY) and Incyte Corporation (INCY) announced that the FDA has extended the time to review the company's NDA for baricitinib for the treatment of rheumatoid arthritis (RA).

ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk

On Jan 13, we issued an updated report on ARIAD Pharmaceuticals, Inc. (ARIA).

Markets Right Now: Banks lead a decline in US stocks

NEW YORK (AP) — The latest on developments in financial markets (All times local):

Stock Market News for January 12, 2017

Benchmarks ended a volatile trading session in the green on Wednesday following President-elect Donald Trump's first news conference in months

Trump Attacks Biotech & Pharma: ETFs Bleed

Trump pledged to initiate a bidding process for drug cost that shed roughly $24.6 billion in 20 minutes from the nine biggest pharmaceutical companies by market cap.

The New #24 Most Shorted Dow Component: Pfizer

The most recent short interest data has been released for the 12/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the...

Merck KGaA, Vertex Announce Tie-Up for Oncology Programs

Merck (MKGAF) and Vertex (VRTX) collaborated for the development and commercialization of four research and development programs for the treatment of cancer.

Monoclonal Antibody Therapeutics Market to be Worth US$245.8 Billion by 2024: Spike in Cancer Cases Around the World to Ensure Swift Uptake, Predicts TMR

ALBANY, New York, January 12, 2017 /PRNewswire/ --

Monoclonal Antibody Therapeutics Market to be Worth US$245.8 Billion by 2024: Spike in Cancer Cases Around the World to Ensure Swift Uptake, Predicts TMR

Several market players are collaborating with local and well-established companies and research facilities to strengthen their position. Transparency Market Research has observed that companies will continue...

Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.

Mylan (MYL) and Biocon Ltd. announced that the FDA had accepted the BLA for their biosimilar version of Herceptin (trastuzumab), MYL-1401O.

Global Hemophilia Treatment Drugs Market to be Worth US$25.1 Billion by 2024: FDA Approvals for Testing Novel Drugs Opens up Opportunities, Says TMR

ALBANY, New York, January 12, 2017 /PRNewswire/ --

Trump Attacks Biotech & Pharma: ETFs Bleed

Trump pledged to initiate a bidding process for drug cost that shed roughly $24.6 billion in 20 minutes from the nine biggest pharmaceutical companies by market cap.

Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment

After President-elect Donald Trump said pharmaceutical companies were ???getting away with murder,??? in how much they charge the government for medicines.

Markets Right Now: Stocks end a wobbly day with solid gains

NEW YORK (AP) — The latest on developments in financial markets (All times local):

Merck: Keytruda+Chemo Gets Priority Review for Lung Cancer

Merck & Co., Inc.'s (MRK) supplemental Biologics License Application (sBLA) for its anti-PD-1 therapy, Keytruda, has been accepted under priority review by the FDA.

US warns of unusual cybersecurity flaw in heart devices

WASHINGTON (AP) — The Homeland Security Department warned Tuesday about an unusual cybersecurity flaw for one manufacturer's implantable heart devices that it said could allow hackers to remotely take...

The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron Pharmaceuticals

The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche’s, Sanofi and Regeneron Pharmaceuticals

Van Meerten Stock Picks

5 Small Caps for Momentum Investors
Today I wanted to find 5 Small Cap stocks with great current momentum so I used Barchart to sort the S&P 600 Small Cap Index stocks first for the most frequent new highs in the last month, then again for technical buy signals of 80.
UTEK +0.40 , CMO +0.05 , LMOS -0.21 , VRTV -1.15 , AFAM -0.75
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH17 +0.03%) are up +0.06% ahead of data on U.S. Dec consumer prices and industrial production, while European stocks are down -0.16% ahead of Thursday's ECB meeting and any indications from the... Read More

Chart of the Day

Chemed (CHE) is the Barchart Chart of the Day.  The hospice care and home service company had a Trend Spotter buy signal, a Weighted Alpha of 27.76+ and gained 19.81% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are mostly steady at midday. Mexico is planning to import at least 20% more corn over the next marketing year. The EIA report is scheduled to come out tomorrow, pushed back by the short week. National average corn price was at 3.30 1/2 l...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.